fusidic acid has been researched along with 1-(1-naphthylmethyl)piperazine in 1 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (1-(1-naphthylmethyl)piperazine) | Trials (1-(1-naphthylmethyl)piperazine) | Recent Studies (post-2010) (1-(1-naphthylmethyl)piperazine) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 38 | 0 | 26 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
1 other study(ies) available for fusidic acid and 1-(1-naphthylmethyl)piperazine
| Article | Year |
|---|---|
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |